The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
SARM1 promotes neuroinflammation and inhibits neural regeneration after spinal cord injury through NF-κB signaling
Open accessAbstract
Our results indicate that SARM1-mediated prodegenerative pathway and neuroinflammation promotes the pathological progress of SCI and anti-SARM1 therapeutics are viable and promising approaches for preserving neuronal function after SCI.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ahuja, C. S., Wilson, J. R., Nori, S., Kotter, M. R. N., Druschel, C., Curt, A., & Fehlings, M. G. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.18 · Cited by 2,441
SARM1 activation triggers axon degeneration locally via NAD + destruction
Gerdts, J., Brace, E. J., Sasaki, Y., DiAntonio, A., & Milbrandt, J. (2015) · Science · doi:10.1126/science.1258366 · Cited by 593
Diverse functions of JNK signaling and c-Jun in stress response and apoptosis
Leppä, S., & Bohmann, D. (1999) · Oncogene · doi:10.1038/sj.onc.1203173 · Cited by 522 · cited 1×
“How did SARM1 deletion reduce the inflammation after SCI? Since NF-κB signaling is a main downstream pathway of SARM1 [52, 53], we next detected the expression of probably related proteins as previously described [54, 55], such as NF-κB, IKB-α, p-JNK, JNK and c-Jun (Figure 7A).”
BackgroundVan Gool, F., Gallí, M., Gueydan, C., Kruys, V., Prevot, P.-P., Bedalov, A., Mostoslavsky, R., Alt, F. W., De Smedt, T., & Leo, O. (2009) · Nature Medicine · doi:10.1038/nm.1906 · Cited by 285 · cited 1×
“, Sigma-Aldrich, catalog #F8557) twice every day until the experiments were terminated [46, 47].”
BackgroundThe NAD biosynthesis inhibitor APO866 has potent antitumor activity against hematologic malignancies
Nahimana, A., Attinger, A., Aubry, D., Greaney, P., Ireson, C., Thougaard, A. V., Tjørnelund, J., Dawson, K. M., Dupuis, M., & Duchosal, M. A. (2009) · Blood · doi:10.1182/blood-2008-08-173369 · Cited by 190
Loreto, A., Hill, C. S., Hewitt, V. L., Orsomando, G., Angeletti, C., Gilley, J., Lucci, C., Sanchez-Martinez, A., Whitworth, A. J., Conforti, L., et al. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104678 · Cited by 131 · cited 1×
“Since SARM1 promotes the Wallerian Degeneration after injury as described previously [49-51], we next examined whether the deletion of SARM1 promoted the recovery of motor functions due to the delay in neuronal degeneration after SCI.”
BackgroundLiu, H.-W., Smith, C. B., Schmidt, M. S., Cambronne, X. A., Cohen, M. S., Migaud, M. E., Brenner, C., & Goodman, R. H. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1809392115 · Cited by 105 · cited 1×
“SARM1 is a recently identified key mediator of WD [8, 9].”
BackgroundSelf-citationTRIM33 switches off Ifnb1 gene transcription during the late phase of macrophage activation
Ferri, F., Parcelier, A., Petit, V., Gallouet, A.-S., Lewandowski, D., Dalloz, M., van den Heuvel, A., Kolovos, P., Soler, E., Squadrito, M. L., et al. (2015) · Nature Communications · doi:10.1038/ncomms9900 · Cited by 70 · cited 1×
“IFN-α primer: forward, 5'-GGATGTGACCTTCCTCAGA CTC-3' and reverse, 5'-ACCTTCTCCTGCGGGAATC CAA-3' [39].”
Pan, Z.-G., & An, X.-S. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.02.115 · Cited by 50 · cited 1×
“How did SARM1 deletion reduce the inflammation after SCI? Since NF-κB signaling is a main downstream pathway of SARM1 [52, 53], we next detected the expression of probably related proteins as previously described [54, 55], such as NF-κB, IKB-α, p-JNK, JNK and c-Jun (Figure 7A).”
Background
Cited by
NF-κB in biology and targeted therapy: new insights and translational implications
Guo, Q., Jin, Y., Chen, X., Ye, X., Shen, X., Lin, M., Zeng, C., Zhou, T., & Zhang, J. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01757-9 · Cited by 2,047
Self-citationXie, Z., Zhang, M., Luo, Y., Jin, D., Guo, X., Yang, W., Zheng, J., Zhang, H., Zhang, L., Deng, C., et al. (2023) · Aging and disease · doi:10.14336/ad.2023.0309 · Cited by 80
“After 3 min of hematoxylin staining, the sections were immersed in eosin for 30 s, and dehydrated using a series of ethanol solutions (75%, 85%, 95%, and 100% ethanol) for 30 seconds, 1 min, 3 min, and 3 min, respectively, and finally cleared in xylene and mounted with neutral resins [36].”
NAD+ hydrolase Sarm1 is a key driver of synapse degeneration and memory loss in Alzheimer’s disease
Fan, F., Joshi, P., Liu, X., Kotturu, S. K., Abiola, M., Liu, Q., & Lou, X. (2025) · doi:10.64898/2025.12.21.695860
Metadata
- Authors
- Liu, H., Zhang, J., Xu, X., Lu, S., Yang, D., Xie, C., Jia, M., Zhang, W., Jin, L., Wang, X., Shen, X., Li, F., Wang, W., Bao, X., Li, S., Zhu, M., Wang, W., Wang, Y., Huang, Z., & Teng, H.
- Venue
- Theranostics
- Publisher
- Ivyspring International Publisher
- Published
- 2021
- Volume
- 11
- Issue
- 9
- Pages
- 4187-4206
- ISSN
- 1838-7640 (ISSN-L)
- OpenAlex
- W3137084308
- Cited by
- 162
- References
- 9
- FWCI
- 12.04
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: SARM1 promotes neuroinflammation and inhibits neural regeneration after spinal cord injury through NF-κB signaling. https://app.cochat.ai/papers/10.7150/thno.49054
- The paper
- Liu, H., Zhang, J., Xu, X., Lu, S., Yang, D., Xie, C., Jia, M., Zhang, W., Jin, L., Wang, X., Shen, X., Li, F., Wang, W., Bao, X., Li, S., Zhu, M., Wang, W., Wang, Y., Huang, Z., & Teng, H. (2021). SARM1 promotes neuroinflammation and inhibits neural regeneration after spinal cord injury through NF-κB signaling. Theranostics. https://doi.org/10.7150/thno.49054
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.